(Q39758692)

English

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

Hongjiang Yan

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Renben Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Fen Zhao

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Kunli Zhu

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Shumei Jiang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Wei Zhao

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Rui Feng

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

language of work or name

0 references

publication date

20 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Acta Radiologica

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

646-650

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Prognostic Evaluation of Nodal Staging Based on the New IASLC Lymph Node Map for Lung Cancer

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Lung Cancer Staging Essentials: The New TNM Staging System and Potential Imaging Pitfalls

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Prognostic stratification using F-18 FDG PET/CT in patients with advanced stage (stage III and IV) non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival.

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

FDG-PET maximum standardised uptake value is associated with variation in survival: analysis of 498 lung cancer patients.

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Metabolic tumor burden predicts for disease progression and death in lung cancer.

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Time-dependent ROC curves for censored survival data and a diagnostic marker

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Partial-volume effect in PET tumor imaging

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters.

1 reference

https://api.crossref.org/works/10.1258%2FAR.2011.100462

21 January 2018

Identifiers

10.1258/AR.2011.100462

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39758692&oldid=2090006319"